Description:

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma NCT00310128 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001EB1B6-5458-308C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001EB1B6-5458-308C-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 3/13/15
Uploaded on:

March 13, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AIDS-Related Lymphoma NCT00310128 Treatment - Lymphoma Disease Activity and Measurement: L01, L02, L03 - 2402629v3.0

No Instruction available.

  1. StudyEvent: Lymphoma Disease Activity and Measurement: L01, L02, L03
    1. No Instruction available.
Header
Reporting Period
Is there lymph node involvement
Nodal involvement evaluation--Lymphoma Disease Activity and Measurement (L01)
Lymph Node Type
cm
cm
Method of Evaluation
Complete response
Is measurable disease present?
Has the patient been diagnosed with a new progression?
Evaluation documented
Lesion Assessment
Extra nodal involvement evaluation--Lymphoma Disease Activity and Measurement (L02)
Extranodal extension
Site of Involvement
Extra Nodal Involvement Evaluation
Objective Status at This Evaluation
What is the present status of the best response
Extra Nodal Involvement Evaluation
Is complete response first observed
Is complete response confirmed (CR)
Extra Nodal Involvement Evaluation
Is complete response uncertain first observed
Is complete response, uncertain, confirmed (CRU)
Extra Nodal Involvement Evaluation
Is partial response first observed
Is partial response confirmed
Extra Nodal Involvement Evaluation
Was a gallium scan, PET scan, or other functional imaging study done
Imaging Result
Please indicate the site of progression
Central Nervous System Progression
CNS - leptomeninges
Brain - parenchymal